US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

HORIZON KINETICS MEDICAL ETF

35.29

+0.33190.95%

Post-market: 35.300.0109+0.03%16:10 EDT

Volume:227

Turnover:8K

Market Cap:16.58M

PE:- -

High:35.30

Open:35.30

Low:35.29

Close:34.96

52wk High:37.90

52wk Low:28.87

Shares:469.95K

Float Shares:469.95K

Volume Ratio:0.09

T/O Rate:0.05%

Dividend:0.41

Dividend Rate:1.16%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Novartis, Alteogen Sign Drug-Technology Deal Worth Up to $3.2 Billion

MT Newswires Live

Alteogen enters option, license agreement with Novartis

Johnson & Johnson : UBS Raises Target Price to $320 from $280

THOMSON REUTERS

Novartis Trial Suspensions to Have Limited Financial Impact

Shinva Medical Secures Class II and III Device Approvals for Advanced Radiotherapy and Thoracoscopic Systems

港股动态：今海医疗科技股价攀升逾4%，中期收益激增逾1.3倍，核心业务向高附加值医疗器械领域转型

Betta Pharma's Hong Kong IPO: A Profit Pioneer Faces Patent Cliffs and Pipeline Doubts

Alkermes EVP R&D, Chief Medical Officer Craig C. Hopkinson Disposes of 9,000 Shares for $422,874

Johnson & Johnson EVP Thomas Cavanaugh Files Initial Beneficial Ownership Statement

Estee Lauder Cos. Cl a Stock Underperforms Tuesday When Compared to Competitors

AbbVie Inc. Stock Underperforms Tuesday When Compared to Competitors Despite Daily Gains

World's Largest Companies by Market Cap (August 2026): Nvidia Retains Top Spot, SpaceX Rebounds 32%, Semiconductor Sector Diverges

H.C. Wainwright says Novartis success in RMS trials does not impact TG’s Briumvi

Novartis MS Trials Open Door to Multibillion-Dollar Sales Opportunity

Johnson & Johnson (JNJ) Stock May Trade At A Discount As Europe Backs Tecvayli

Simply Wall St.

Novartis Stock (NVS) Pops as Multiple Sclerosis Drug Shows Positive Results in Late-Stage Trials

Novartis AG Stock (NVS) Moved Up by 6.54% on Sep 1: Drivers Behind the Movement

Novartis's Multiple Sclerosis Trial Results Match Best Hopes

US Stock Alert: Novartis Gains 5% On Positive Late-Stage Trial Results For MS Oral Therapy

Novartis up Nearly 6%, on Pace for Largest Percent Increase Since March 2023

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/MEDX/news?page=15"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MEDX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEDX\",,,,,undefined,":{"symbol":"MEDX","market":"US","secType":"STK","nameCN":"HORIZON KINETICS MEDICAL ETF","latestPrice":35.2891,"timestamp":1789416000000,"preClose":34.9572,"halted":0,"volume":227,"hourTrading":{"tag":"盘后","latestPrice":35.3,"preClose":35.2891,"latestTime":"16:10 EDT","volume":7,"amount":247.0237,"timestamp":1789416603919,"change":0.0109,"changeRate":0.000309,"amplitude":0},"delay":0,"changeRate":0.009494467520281871,"floatShares":469946,"shares":469946,"eps":0,"marketStatus":"Not Yet Opened","change":0.3319,"latestTime":"09-14 16:00:00 EDT","open":35.3,"high":35.3,"low":35.2891,"amount":8052,"amplitude":0.000312,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789459200000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":34.9572,"sharesOutstanding":569946,"nav":34.94,"aum":16419913.24,"dividendRate":0.01159,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":35.3,"preClose":35.2891,"latestTime":"16:10 EDT","volume":7,"amount":247.0237,"timestamp":1789416603919,"change":0.0109,"changeRate":0.000309,"amplitude":0},"volumeRatio":0.087916},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEDX\",,,,,undefined,":{"symbol":"MEDX","floatShares":469946,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.087916,"shares":469946,"dividePrice":0.409,"high":35.3,"amplitude":0.000312,"preClose":34.9572,"low":35.2891,"week52Low":28.8652,"pbRate":"--","week52High":37.9,"institutionHeld":0,"latestPrice":35.2891,"eps":0,"divideRate":0.01159,"volume":227,"delay":0,"ttmEps":0,"open":35.3,"prevYearClose":33.2024,"prevWeekClose":34.9572,"prevMonthClose":36.417,"prevQuarterClose":36.7138,"fiveDayClose":36.6906,"twentyDayClose":35.6938,"sixtyDayClose":34.2263},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MEDX\",params:#limit:5,,,undefined,":[{"date":"2025-12-23","symbol":"MEDX","amount":0.4088,"announcedDate":"2025-12-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-23","defaultRemindTime":1766500200000,"name":"HORIZON KINETICS MEDICAL ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-23","currency":"USD","dateTimestamp":1766466000000,"payDate":"2025-12-24"},{"date":"2024-12-24","symbol":"MEDX","amount":0.502335,"announcedDate":"2024-12-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-24","defaultRemindTime":1735050600000,"name":"HORIZON KINETICS MEDICAL ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-24","currency":"USD","dateTimestamp":1735016400000,"payDate":"2024-12-26"},{"date":"2023-12-27","symbol":"MEDX","amount":1.379798,"announcedDate":"2023-12-26","type":"dividend","market":"US","newRecordDate":"2023-12-28","defaultRemindTime":1703687400000,"name":"HORIZON KINETICS MEDICAL ETF","recordDate":"2023-12-29","payableDate":"2023-12-28","currency":"USD","dateTimestamp":1703653200000,"payDate":"2023-12-29"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MEDX\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-27","recordDate":"2023-12-28","paymentDate":"2023-12-29","value":1.379798,"currency":"USD"},{"executeDate":"2024-12-24","recordDate":"2024-12-24","paymentDate":"2024-12-26","value":0.502335,"currency":"USD"},{"executeDate":"2025-12-23","recordDate":"2025-12-23","paymentDate":"2025-12-24","value":0.4088,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MEDX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MEDX\",pageSize:20,pageCount:15,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664162238","title":"Novartis, Alteogen Sign Drug-Technology Deal Worth Up to $3.2 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2664162238","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664162238?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:35","pubTimestamp":1788348951,"startTime":"0","endTime":"0","summary":"Novartis  has signed an option and licensing agreement with South Korean biotech Alteogen to develop and sell subcutaneous versions of multiple Novartis drugs using its ALT-B4 technology, Alteogen said Wednesday.The company said ALT-B4 is designed to convert biologic medicines typically given through intravenous infusions into faster injections under the skin.If Novartis exercises all options and all milestones are met, Alteogen could receive up to $3.223 billion, including option fees, development and commercial milestones, and royalties on product sales, it added.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","IE00BJT1NW94.SGD","LU0211331839.USD","IE0009355771.USD","LU0208291251.USD","IE00B4R5TH58.HKD","BK4578","MEDX","IE00B2B36J28.USD","PPH","BK4588","LU0070302665.USD","LU0320765489.SGD","BK4532","IE00BFTCPJ56.SGD","IE0002141913.USD","IE00BJJMRZ35.SGD","NVS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664165388","title":"Alteogen enters option, license agreement with Novartis","url":"https://stock-news.laohu8.com/highlight/detail?id=2664165388","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664165388?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:15","pubTimestamp":1788347740,"startTime":"0","endTime":"0","summary":"Alteogen announced that it has entered into an option and license agreement with Novartis (NVS) for the development and commercialization of subcut...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alteogen-enters-option-license-agreement-with-novartis-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alteogen-enters-option-license-agreement-with-novartis-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","MEDX","IE00B4R5TH58.HKD","NVS","IE00BJT1NW94.SGD","LU0070302665.USD","BK4007","IE00B2B36J28.USD","PPH","IE0002141913.USD","LU0320765489.SGD","IE00BFTCPJ56.SGD","BK4578","IE0009355771.USD","IE00BJJMRZ35.SGD","BK4532","LU0211331839.USD","BK4585","LU0208291251.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664815119","title":"Johnson & Johnson : UBS Raises Target Price to $320 from $280","url":"https://stock-news.laohu8.com/highlight/detail?id=2664815119","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664815119?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:02","pubTimestamp":1788346971,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nAZN4THURS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["JNJ","LU2471134523.USD","LU0053666078.USD","LU0792757196.USD","BK4533","XLV","LU1145028129.USD","BMED","JDOC","FTXH","BK4592","LU1066053197.SGD","IYH","BK4534","VHT","LU0795875169.SGD","LU1066051498.USD","LU1929549753.HKD","LU1059921491.USD","BK4568","TRUH","LU0072461881.USD","GDOC","LU0912757837.SGD","LU0289739699.SGD","FHLC","LU2430703178.SGD","LU0985320562.USD","LU1244550494.USD","LU1914381329.SGD","LU0345770308.USD","LU0345770993.USD","LU0426412945.USD","LU2089984988.USD","MEDX","IE000BZT7R73.USD","SG9999001440.SGD","LU1228905037.USD","RXL","IE00B42XCP33.USD","IXJ","LU0098860793.USD","LU0210528500.USD","PJP","LU0210536198.USD","IHE","IE00BLSP4239.USD","LU1778281490.HKD","SG9999013999.USD","LU1983299246.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664920892","title":"Novartis Trial Suspensions to Have Limited Financial Impact","url":"https://stock-news.laohu8.com/highlight/detail?id=2664920892","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664920892?lang=en_us&edition=fundamental","pubTime":"2026-09-02 16:15","pubTimestamp":1788336900,"startTime":"0","endTime":"0","summary":"0815 GMT - Novartis's decision to suspend several clinical trials for a cell therapy after three patients died is expected to have a limited financial impact, Citi analysts say in a research note. Pending further updates, the news reduces the likelihood that the Swiss drugmaker's next-generation cell-therapy platform--which aims to accelerate the process of T-cell expansion to treat autoimmune diseases--could provide a future boost, the analysts say. However, the treatment was still in midstage trials, and Citi's current peak sales estimate stands at only $440 million. Novartis shares fall 0.6%.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","BK4588","BK4585","PPH","BK4578","LU0211331839.USD","IE0002141913.USD","IE00B4R5TH58.HKD","IE00B2B36J28.USD","LU0208291251.USD","LU0070302665.USD","IE00BFTCPJ56.SGD","MEDX","BK4532","IE0009355771.USD","LU0320765489.SGD","NVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186287506","title":"Shinva Medical Secures Class II and III Device Approvals for Advanced Radiotherapy and Thoracoscopic Systems","url":"https://stock-news.laohu8.com/highlight/detail?id=1186287506","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186287506?lang=en_us&edition=fundamental","pubTime":"2026-09-02 15:51","pubTimestamp":1788335497,"startTime":"0","endTime":"0","summary":"Shinva Medical Instrument Co.,Ltd. (600587.SH) has announced that it recently received the Medical Device Registration Certificate from China's National Medical Products Administration, while its...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTH","09996","BK1583","159883","BK1574","RSPH","LNGR","BK0028","LGHT","BK1100","AGNG","GDOC","BK0188","HART","600587","MDEV","BK0251","MEDX","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184201272","title":"港股动态：今海医疗科技股价攀升逾4%，中期收益激增逾1.3倍，核心业务向高附加值医疗器械领域转型","url":"https://stock-news.laohu8.com/highlight/detail?id=1184201272","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184201272?lang=en_us&edition=fundamental","pubTime":"2026-09-02 14:10","pubTimestamp":1788329416,"startTime":"0","endTime":"0","summary":"今海医疗科技（02225）股价今日表现活跃，盘中涨幅一度超过5%。截至最新交易时段，该股上涨4.08%，报4.72港元，成交额达628.74万港元。据近期披露的2026年中期业绩显示，公司在营收扩张与盈利质量方面均呈现积极态势。报告期内，集团实现收益3402.1万新加坡元，较去年同期大幅增长134.16%，彰显出强劲的销售增长动能。从业务结构来看，2026年上半年，公司收入构成实现显著优化，战略重...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KCAI","09996","BK4588","GDOC","PTH","LNGR","159883","02225","BK1583","RSPH","VXUS","MEDX","MDEV","AGNG","BK1100","BK1150","BK4585","BK1574","IEIH","LGHT","HART"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185564913","title":"Betta Pharma's Hong Kong IPO: A Profit Pioneer Faces Patent Cliffs and Pipeline Doubts","url":"https://stock-news.laohu8.com/highlight/detail?id=1185564913","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185564913?lang=en_us&edition=fundamental","pubTime":"2026-09-02 09:20","pubTimestamp":1788312055,"startTime":"0","endTime":"0","summary":"After a five-year hiatus, Betta Pharmaceuticals Co., Ltd. is once again knocking on the doors of the Hong Kong stock exchange, carrying the mantle of being the \"first domestic innovative targeted...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159992","BK0060","REDS","BK0239","300558","BK1161","IBBQ","06978","BK1574","MEDX","BK4127","KCE","IPOS","FRHC","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664864142","title":"Alkermes EVP R&D, Chief Medical Officer Craig C. Hopkinson Disposes of 9,000 Shares for $422,874","url":"https://stock-news.laohu8.com/highlight/detail?id=2664864142","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664864142?lang=en_us&edition=fundamental","pubTime":"2026-09-02 07:09","pubTimestamp":1788304180,"startTime":"0","endTime":"0","summary":"Alkermes EVP R&D, Chief Medical Officer Craig C. Hopkinson disposes of 9,000 shares for $422,874Craig C. Hopkinson, EVP R&D, Chief Medical Officer, sold 9,000 ordinary shares on Sep. 1 at USD 46.99.He","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDLgbNz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Alkermes EVP R&D, Chief Medical Officer Craig C. Hopkinson Disposes of 9,000 Shares for $422,874","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALKS","FBT","PSIL","MEDX","IBRN","PSCH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664386900","title":"Johnson & Johnson EVP Thomas Cavanaugh Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2664386900","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664386900?lang=en_us&edition=fundamental","pubTime":"2026-09-02 04:53","pubTimestamp":1788295990,"startTime":"0","endTime":"0","summary":"Johnson & Johnson EVP Thomas Cavanaugh files initial beneficial ownership statementJohnson & Johnson EVP WW Chair, Innovative Med. Thomas Cavanaugh filed a Form 3 disclosing 499 common shares, includi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL58rn8Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2213496289.HKD","IHE","JDOC","PJP","IE000F7OJYX1.SGD","LU0689472784.USD","VHT","LU1221951046.USD","BMED","LU2750360997.AUD","RXL","IE00B19Z3581.USD","SG9999013999.USD","IE00BJT1NW94.SGD","LU1032466523.USD","IE00BSNM7G36.USD","LU1430594728.SGD","LU2112291526.USD","LU2430703251.USD","GDOC","FTXH","LU0994945656.USD","LU1732800096.USD","XLV","IE00BLSP4452.SGD","IE00BKVL7J92.USD","FHLC","IE00BJJMRZ35.SGD","LU0545562505.USD","LU2133065610.SGD","IE00BVYPNW00.USD","LU0289739699.SGD","MEDX","IYH","TRUH","LU0964807845.USD","LU0203347892.USD","IE00BVYPNV92.GBP","LU0234572021.USD","LU2602419157.SGD","BK4568","LU2487616109.SGD","LU1228905540.USD","LU1496350502.SGD","IE000WAW04H5.SGD","LU1929549753.HKD","JNJ","IXJ","LU0943347566.SGD","BK4504"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664869005","title":"Estee Lauder Cos. Cl a Stock Underperforms Tuesday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2664869005","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664869005?lang=en_us&edition=fundamental","pubTime":"2026-09-02 04:53","pubTimestamp":1788295980,"startTime":"0","endTime":"0","summary":"DJ Estee Lauder Cos. Cl A Stock Underperforms Tuesday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Estee Lauder Cos. Cl A  shed 2.25% to $100.00 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index  falling 0.71% to 7,631.47 and Dow Jones Industrial Average  falling 0.79% to 52,766.88.This was the stock's third consecutive day of losses.Estee Lauder Cos. Cl A closed 17.79% short of its 52-week high of $121.64, which the company reached on February 3rd.The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson  rose 2.01% to $271.19, Procter & Gamble Co.  rose 0.75% to $146.21, and Coty Inc. Cl A  fell 0.35% to $2.84.Trading volume  remained 177,738 below its 50-day average volume of 3.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 1, 2026.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0210536198.USD","IXJ","SG9999014559.SGD","LU2471134879.HKD","LU2404859667.USD","EL","TRUO","XLP","IE00BZ1G4Q59.USD","COTY","LU0795875169.SGD","JNJ","LU1057294990.SGD","TRUH","IE00B2B36J28.USD","LU1059921491.USD","GDOC","PJP","IYH","LU0098860793.USD","LU0072461881.USD","GLAM","LU0289739699.SGD","FSTA","MEDX","LU1267930813.SGD","LU0432979614.USD","RXL","IE00B19Z3B42.SGD","JDOC","FHLC","LU1551013342.USD","VHT","IE00BDGV0183.EUR","BK4568","LU0122379950.USD","IE000F7OJYX1.SGD","LU0237698245.USD","LU0882574055.USD","XLV","BMED","IHE","IE00BVYPNV92.GBP","LU0234572021.USD","LU1894683348.USD","PG","SG9999014542.SGD","UGE","IE00BJJMRZ35.SGD","FTXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664869930","title":"AbbVie Inc. Stock Underperforms Tuesday When Compared to Competitors Despite Daily Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2664869930","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664869930?lang=en_us&edition=fundamental","pubTime":"2026-09-02 04:32","pubTimestamp":1788294720,"startTime":"0","endTime":"0","summary":"DJ AbbVie Inc. Stock Underperforms Tuesday When Compared To Competitors Despite Daily GainsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of AbbVie Inc.  rose 1.39% to $259.99 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index  falling 0.71% to 7,631.47 and Dow Jones Industrial Average  falling 0.79% to 52,766.88.This was the stock's second consecutive day of gains.AbbVie Inc. closed 2.80% short of its 52-week high of $267.47, which the company reached on July 29th.The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson  rose 2.01% to $271.19, Pfizer Inc.  rose 0.32% to $28.55, and Amgen Inc.  rose 1.92% to $438.12.Trading volume  remained 3.0 million below its 50-day average volume of 6.8 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 1, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PPH","MEDX","LU0708994859.HKD","ABBV","GLAM","SG9999015952.SGD","LU1929549753.HKD","LU1496350502.SGD","SG9999015986.USD","LU1551013342.USD","LU0128525929.USD","LU2347655156.SGD","BK4559","IE0002141913.USD","LU1989772840.SGD","LU0726765562.USD","PJP","LU0472753341.HKD","LU0820561818.USD","LU0234570918.USD","SG9999011175.SGD","LU0738911758.USD","LU1732800096.USD","LU1551013425.SGD","BK4581","LU0198837287.USD","LU1162221912.USD","LU0949170772.SGD","IE00BBT3K403.USD","LU2023251221.USD","BK4585","LU2237443978.SGD","IE000F7OJYX1.SGD","LU0417517546.SGD","LU2433249047.HKD","IE0000B7K699.USD","IE00BGHQF631.EUR","BK4566","LU0861579265.USD","IE00B42XCP33.USD","FTXH","LU0965508806.USD","LU0289739343.SGD","LU2237443382.USD","SG9999015978.USD","LU0211327993.USD","LU1989772923.USD","LU0310799852.SGD","LU0985320562.USD","LU1585245621.USD","LU1934455194.USD","LU1496350171.SGD","LU0158827948.USD","LU2089984988.USD","LU0256863902.USD","IE0009355771.USD","LU2129689605.HKD","LU0965509010.AUD","LU0211328371.USD","LU0795875086.SGD","LU0795875169.SGD","IE00B19Z3B42.SGD","LU1061106388.HKD","LU0942090050.USD","SG9999003800.SGD","IE00BJT1NW94.SGD","IE00BVYPNW00.USD","LU2125909593.SGD","LU0098860793.USD","SG9999001440.SGD","LU1989771016.USD","JDOC","LU1291159041.SGD","LU1934455277.USD","LU0882574055.USD","LU0432979614.USD","LU2089284900.SGD","IE00BDGV0183.EUR","BK4533","LU0320765646.SGD","LU0661504455.SGD","LU0823416689.USD","LU0965509283.SGD","LU0203345920.USD","LU1023059063.AUD","LU1244550577.SGD","LU1057294990.SGD","LU0058720904.USD","XLV","LU0289961442.SGD","LU2237443895.HKD","IE00BLSP4239.USD","LU1074936037.SGD","LU1670627923.USD","LU0170899867.USD","IE0004445239.USD","IE00BVYPNV92.GBP","LU1267930490.SGD","LU0289739699.SGD","FHLC","LU2133065610.SGD","BK4534","LU1093756168.USD","IYH","IE00BN8TJ469.HKD","LU0069063385.USD","LU1244550221.USD","LU1839511570.USD","LU2347655073.USD","LU1718418525.SGD","LU0234572021.USD","LU2112291526.USD","IE00BLSP4452.SGD","LU1037948541.HKD","IXJ","LU0310800379.SGD","LU0912757837.SGD","LU1267930573.SGD","VHT","LU0545039389.USD","LU1732799900.SGD","LU2237443622.USD","LU1983299246.USD","IE00B3PB1722.GBP","LU0859254822.USD","LU0057025933.USD","LU1037948897.HKD","LU0203347892.USD","LU0965509101.SGD","LU2125909247.SGD","IE00BSNM7G36.USD","LU2129689431.USD","IE00B4R5TH58.HKD","BK4550","IE000BZT7R73.USD","SG9999015945.SGD","LU0456855351.SGD","AGNG","LU0689626769.HKD","LU0256863811.USD","BK4588","LU1244550494.USD","LU0820561909.HKD","IE0002270589.USD","IE000MB6IJN5.SGD","IE00B2B36J28.USD","IE000WAW04H5.SGD","LU0395794307.EUR","LU1670628061.USD","LU1430594728.SGD","LU2468319806.SGD","LU0868494617.USD","LU1003077747.HKD","LU2357627491.SGD","LU0868494708.USD","LU0511384066.AUD","IE00BFTCPJ56.SGD","LU1236620750.USD","IE000SO60NU8.SGD","LU1236620834.HKD","TRUH","LU0029864427.USD","LU1093756325.SGD","LU2089283258.USD","LU1934455863.HKD","LU0553294199.USD","LU0124676726.USD","LU0943347566.SGD","RXL","BK4139","IE00BJJMRZ35.SGD","LU0114720955.EUR","LU0689472784.USD","LU0122379950.USD","LU1923622614.USD","LU2087621335.USD","LU2129689514.USD","IE00B19Z3581.USD","LU2237443465.HKD","LU2237443549.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664866364","title":"World's Largest Companies by Market Cap (August 2026): Nvidia Retains Top Spot, SpaceX Rebounds 32%, Semiconductor Sector Diverges","url":"https://stock-news.laohu8.com/highlight/detail?id=2664866364","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664866364?lang=en_us&edition=fundamental","pubTime":"2026-09-02 03:09","pubTimestamp":1788289773,"startTime":"0","endTime":"0","summary":"As of August 2026, Nvidia retained its top spot globally with a market capitalization of $5.32 trillion, closely followed by Apple, Microsoft, and Alphabet. The biggest change in the global market cap rankings in August was SpaceX, whose market cap rose to $1.89 trillion with a monthly gain of 32.59%, while Tesla, SK Hynix, and Micron Technology also recorded sizable gains. The Philadelphia Semiconductor Index rose 1.98% in August, staging a modest recovery from a sharp 20.61% correction in July.","market":"us","thumbnail":"https://resource.tradingkey.com/uploads/20260305/magnificent-seven-4a39fde5058b400d83c9d523fd94f7b2.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20260305/magnificent-seven-4a39fde5058b400d83c9d523fd94f7b2.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/analysis/stocks/us-stocks/262144678-largest-company-us-stock-august-2026-ai-nvidia-spacex-semiconductor-micron-skhy-tradingkey","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0096362180.USD","GGLL","LU1935042488.USD","BK4574","BK4579","CGNG","LU0310800965.SGD","LU0994945656.USD","CORO","NVDA","LU1951198990.SGD","LU2403377893.USD","LU2750360641.GBP","NVDD","LU0264606111.USD","IE00B19Z9Z06.USD","LU0471298777.SGD","LU0784385840.USD","LU1506573853.SGD","LU2272731865.HKD","LU0395794307.EUR","YSPC","BK4561","LU2125909593.SGD","LU0345774631.USD","AGNG","HK0000306685.HKD","TYLG","BK4587","LU0426412945.USD","AAPD","IE0004086264.USD","EGGY","MIC","LU0426417589.USD","LU0225283273.USD","LU2244417387.USD","TSL","IE0034235303.USD","LLII","LU0354030511.USD","META","NVD3.UK","LU2506951792.HKD","SPTE","LU1670710661.SGD","LU0965509010.AUD","TSLA","LU2168564149.EUR","BK4527","LU1629891620.HKD","TWSC","GB00BDT5M118.USD","SG9999001077.SGD","TINS","2NVD.UK","LU1674673691.USD","IE000BZT7R73.USD","LU2468319806.SGD","LU0786609619.USD","MEDI","IE00B19Z8X17.USD","IE00B3PB1722.GBP","LU0070302665.USD","LU1228905540.USD","LU0143863198.USD","MEMX","AIPI","USD","BK4501","LTL","LU0432979614.USD","LU0823417653.USD","IE00BBT3K403.USD","LU2089283258.USD","LU0949170426.SGD","BK4505","LU2089984988.USD","TSLZ","METQ","LU0823411888.USD","LU0359201612.USD","LU1291159041.SGD","LU1564329628.SGD","LU2048586759.USD","SGXZ44715902.SGD","SGXZ81514606.USD","LU1914381329.SGD","LU2047632596.USD","LU0823414478.USD","LU0878004406.USD","LU1093756168.USD","ELIS","LU1989763005.USD","LU2242649171.HKD","LU0314104364.USD","HULL","LU1267930227.SGD","LU1934455863.HKD","LU2381873111.SGD","LU1221951129.SGD","LU0648001328.SGD","LU0210528500.USD","LU1582986433.USD","LU1066051498.USD","TEST","LU0234570918.USD","AVSE","LU2420271590.USD","LU0878005551.USD","TSLP","EFIV","LU0256863902.USD","LU3102509885.SGD","HK0000914686.HKD","IE00B4JS1V06.HKD","LU1935042991.SGD","LU2210149790.SGD","WARP","LU0109392836.USD","SMSFTmain","LU1162221912.USD","LU1489326972.SGD","NVDX","IE00B2B36J28.USD","LU2506952097.USD","NVDB","IE00BZ199S13.USD","FCOM","LU0868494617.USD","SKUU","LU2999663052.SGD","LU0345768153.USD","LU0353189680.USD","BK4535","IE0003U64NQ7.SGD","LU0211328371.USD","LU2237443895.HKD","LU1244550494.USD","VHT","WDNA","LU0158827948.USD","LU0788109477.HKD","RULE","IE00BDRTCR15.USD","AAPW","BK4575","BK4097","LU2362540622.SGD","IE00BD6J9T35.USD","LU2430703251.USD","LU1791710582.SGD","TSMG","IE00BJT1NW94.SGD","SPCF","LU0094547139.USD","BK4559","AVGC","TTEQ","XNTK","PPH","LU2054465674.USD","IE00B3SWFQ91.USD","LU0127658192.USD","LU2462591277.SGD","PJP","LU1430594728.SGD","BK4524","LU0162691827.USD","LLY","VOX","BK4566","LU1852331112.SGD","BK4551","IE000M9KFDE8.USD","LU0545562505.USD","AVGG","LU1196500208.SGD","LU2452424414.USD","AAPY","LU2065169927.USD","LU0276348264.USD","LU1778281490.HKD","TSYY","AVL","SPCQ","LU0109394709.USD","MUU","LU0266013472.USD","LU1720051017.SGD","LU1989764748.USD","IE00BZ1G4Q59.USD","LU1069347547.HKD","LU1093756325.SGD","LU2491050071.SGD","AMZG","IE00BVYPNQ40.USD","LU0048584097.USD","LU2148611432.USD","LU1032466523.USD","BK4581","IE00B3S45H60.SGD","LU1023057109.AUD","KNOW","LU0823421333.USD","BRK.A","IXN","AVGU","LU1564329032.USD","LU1883839398.USD","TSLY","MSFY","IYH","SK","AVEM","LU0882574139.USD","LU0640476718.USD","LU0889565833.HKD","LU1035773651.USD","IE0004445015.USD","IETC","THNR","HK0000304805.HKD","LU2487616109.SGD","BK4516","LU0726765562.USD","LU2764262908.HKD","LU0302445910.USD","LU2102340556.USD","LU1983260115.SGD","LU0879622024.SGD","LU0069063385.USD","IDRV","LU2954938101.SGD","LU1670710588.SGD","RTH","LU1435385759.SGD","IE0004445239.USD","LU0310800379.SGD","LU0096364046.USD","BK4548","TDIV","USAW.SI","TSMZ","LU0029864427.USD","LU0488056044.USD","AIQ","LU1670711040.USD","LU0289961442.SGD","LU0965509101.SGD","BK4122","FDRV","LU0011850046.USD","LU0950375773.USD","UMMA","LU2065170008.USD","AMZU","LU2290526834.HKD","IE00B5TLWC47.USD","LU2602419157.SGD","LU1821325948.USD","BK4567","LU2168564495.EUR","LU1880398471.USD","LOFF","LU1803068623.USD","EMM","LLYZ","LU2417539215.USD","FBL","LU0347712357.USD","LU0661504455.SGD","SG9999004220.SGD","BK4141","LU0345770993.USD","LU0742534661.SGD","LU0072462343.USD","LU0323591593.USD","LU1718418525.SGD","LU1861559042.SGD","IE00B7KXQ091.USD","LU2357125470.USD","03145","ONLN","WSPC","LU0314106906.USD","CURE","09388","SG9999000418.SGD","RSPC","IE0000B7K699.USD","07709","AAPB","LU0308772762.SGD","LU0511384066.AUD","LU1046421795.USD","LU0057025933.USD","LU0882747503.HKD","LU1366192091.USD","IHE","IE00BN29S564.USD","LU2357627491.SGD","SKHA","LU1037948897.HKD","LU0310799852.SGD","LU1935043023.USD","LU1334329650.SGD","BK4532","SG9999001176.USD","LU0724617625.USD","LU1496350502.SGD","PTF","LU1582987597.SGD","GGLS","LU1894683264.USD","LU0689626769.HKD","SMETAmain","BK4585","LU0823413587.USD","LU2213496289.HKD","MUYY","WISE","IE00B1BXHZ80.USD","LU1303367103.USD","LU2360106780.USD","LU1153585028.USD","LU1221951046.USD","LU0820561909.HKD","LU1202635105.USD","LU1366333091.USD","IE000WAW04H5.SGD","LU0528227936.USD","LU0444973449.USD","LU2125909759.SGD","SKHN","LU1211504680.USD","SG9999011175.SGD","MSFU","LU2458330243.SGD","LU1989764664.SGD","SKDD","GOOP","LU1066053197.SGD","LU0477156797.USD","LU0385154629.USD","CANC","CNEQ","LU1228905037.USD","LU1301847155.USD","LU0138981039.USD","LU2028103732.USD","BK4577","LU2746668461.USD","BK4089","MSFD","AIS","LU0708995401.HKD","LU1814569148.SGD","LU2237443382.USD","IE00BKPKM429.USD","SKHZ","IE00BFTCPJ56.SGD","LU0323239441.USD","SG9999015986.USD","LU0965509283.SGD","LU1037948541.HKD","LU1803068979.SGD","XLC","IE0002270589.USD","LU2322448957.HKD","LU1340139317.AUD","TSMY","LU2236285917.USD","LU2272731600.USD","LU2360108059.USD","NVDS.UK","XLV","AVGW","SG9999004303.SGD","TSLI","LU1923622614.USD","LU0784384876.USD","LU1400636657.SGD","IE00B775SV38.USD","IE00B19Z9P08.USD","LU0320765992.SGD","LU0353189763.USD","IE00BFXG0V08.USD","LU1868838027.USD","CHPX","BK4549","LU1084165304.USD","LU2326559502.SGD","SMHX","LU2471134796.USD","HK0000320264.USD","LU2077746001.SGD","LU0187121727.USD","XDAT","LU1032955483.USD","LU0957808578.USD","BK4591","ANV","LU2461242641.AUD","THMR","LU2506951958.HKD","LU0642271901.SGD","LU2491049909.HKD","LU0238689110.USD","LU2023250843.SGD","IE00BQXX3F31.USD","LU0006306889.USD","LU2108987350.USD","LU2750360997.AUD","LOFD","METG","SPCH","GAMR","LU2065171402.SGD","LU0106261372.USD","IE00BJTD4V19.USD","LU0496365809.HKD","CRSH","DISK","LU1145028129.USD","NVII","LU0128525689.USD","FBYY","STSM","LU0061474960.USD","LU0203202063.USD","VT","LU1868837565.USD","IE00BFMHRM44.USD","MSFC","METW","BK4176","METU","LU0072462426.USD","SOXY","LU0158827781.USD","LU1732800096.USD","LU2458330169.SGD","LU2317271919.USD","MUG","LU0683600562.USD","LU1236620750.USD","LU0342679015.USD","LU0359201885.HKD","LU0203201768.USD","LU1992135472.HKD","LU1642822529.SGD","LU2506952170.USD","LU1670628061.USD","LU2362541273.HKD","LU0823413660.USD","LU2764263203.CNY","LU1551013425.SGD","LU2275660780.HKD","LU0787776722.HKD","LU1043141396.HKD","LU2764263039.SGD","NVD2.UK","LU0964807845.USD","MARS","BK4550","LU0942090050.USD","LU0979878070.USD","JDOC","SG9999014898.SGD","LU2357305700.SGD","IE00BFXG1179.USD","LU2089284900.SGD","SG9999015978.USD","LU0095938881.EUR","LU2756315664.SGD","IE000KEQY171.SGD","IE00BVYPNW00.USD","BK4604","IE00BGHQF631.EUR","SOXX","LU0122379950.USD","BK4588","LU0211331839.USD","LU1551013342.USD","AMZP","BK4099","LU2471134952.CNY","USXF","LU2237438978.USD","LU0320765059.SGD","LU1983299246.USD","LU0107464264.USD","LU0109391861.USD","ORBX","LU1868836591.USD","BK4534","LU1868836757.USD","LU2463028550.USD","LU1868837136.USD","LU0052756011.USD","LU2361044949.HKD","CLIX","LU0738911758.USD","MSFX","LU1069344957.HKD","LU0320765489.SGD","FDTX","NVC","LU0960925559.SGD","TSM","LU0251131958.USD","IE0034235295.USD","SPCX","LU1235294995.USD","LU2095319765.USD","LU1400636574.HKD","LU0859254822.USD","SG9999014567.USD","IE0034235188.USD","CHAT","LU0823434583.USD","IE0005OL40V9.USD","LU0320765646.SGD","TSLO","IE00BJJMRY28.SGD","LU0157215616.USD","LU0965508806.USD","SKHYV","LU2491050154.USD","SPAX","BK4598","LU0345769128.USD","MSFW","LU0957791311.USD","LU1066051225.USD","LU1564329461.SGD","MACW.SI","LU1003077747.HKD","LU2756315318.SGD","NVIW.SI","LU0795875086.SGD","VGT","IE00B894F039.SGD","IE00BKVL7J92.USD","BK4555","LU2250418816.HKD","IE00BLSP4452.SGD","IE00BVYPNV92.GBP","LU2168563687.JPY","ELIL","FTXH","SG9999015952.SGD","LU0784383803.USD","AMZY","LU2092627202.USD","LU2237443549.SGD","LU1571399168.USD","TRUC","STSLAmain","LU2097344431.USD","LU2271345857.HKD","LU2211815571.USD","SAAPLmain","BK4170","SG9999014559.SGD","XLK","BK4503","LU0274383776.USD","LU0143551892.USD","SG9999014906.USD","IE00BJJMRZ35.SGD","IE00BDGV0183.EUR","LU0267386448.USD","LU2360032135.SGD","LU2168564065.EUR","LU2543165471.USD","SG9999003800.SGD","NVDS","LU0889565916.HKD","SG9999014575.USD","SG9999014880.SGD","LU2191332357.HKD","LU0289739699.SGD","LU0976567544.SGD","LU2347655073.USD","MHIP","SKHL","LU1935043536.SGD","LU0390134368.USD","MU","TSLW","LU1974910355.USD","EMC","LU0823417737.USD","LU0072461881.USD","NVDQ","HBMX","BK4538","IE00BMCWC346.EUR","LU2361045086.USD","LU0690374615.EUR","APLY","LU2294711713.HKD","IE00B3M56506.USD","LU2462591350.SGD","AMZO","SGXZ57979304.SGD","CGGO","LU0541502299.USD","AAPL","LU1935042215.USD","LU2237443622.USD","LU1400636491.USD","AVXC","LU1548497426.USD","IE00BJTD4N35.SGD","AMAA","LU2065171311.SGD","LU0949170772.SGD","AIFD","LU0708994859.HKD","IE000F7OJYX1.SGD","AAPE","IE00BFSS8Q28.SGD","LU0348723411.USD","SG9999018865.SGD","SMU00main","LU1697837992.HKD","LU0757359368.USD","LU2249611893.SGD","CGBL","SGXZ31699556.SGD","BK4571","IE00BZ9MQY76.HKD","FTXL","LU1242518931.SGD","LU1261432733.SGD","LU1282649067.USD","LU1880398554.USD","07388","TSLG","AZYY","IE0002141913.USD","BK4596","LU0082616367.USD","LU0211326755.USD","LU0552385451.USD","MSFO","IE00BK4W5L77.USD","LU0175139822.USD","LU0289739343.SGD","ESIM","LU1923622291.USD","GOOW","LU2168564222.USD","LU2552382132.HKD","IE00BQXX3C00.GBP","TSLQ","LU2637965513.SGD","TSLL","LU0058720904.USD","LU1951200564.SGD","LU1267930490.SGD","LU2279689827.SGD","LU0359202008.SGD","LU2125154778.USD","NVDW","LU0345768740.USD","HAKY","LU1712237335.SGD","LU0080751232.USD","LU1066051811.HKD","LU0894486033.HKD","LU1316542783.SGD","LU2087625088.SGD","LU2552382058.USD","SOXQ","LU2413666426.HKD","FBY","IE000YTNTUN2.SGD","LU2552382215.SGD","LU1188199696.SGD","LU1670627923.USD","LU0210533765.USD","IE00BMPRXR70.SGD","LU1235295455.SGD","LU2362541513.USD","LU2041044095.USD","LU1116320901.HKD","BAI","BK4526","LU1791710400.SGD","LU2404859667.USD","IE00B19Z8W00.USD","TLA","LU2265009873.SGD","IE00BMPRXN33.USD","SNVD.UK","WATS","LU0316494557.USD","IE00BKDWB100.SGD","LU2264538146.SGD","LU0795875169.SGD","LU1242518857.USD","LU1267930813.SGD","GB00B4LPDJ14.GBP","LU2092937221.SGD","LU1236620834.HKD","CGDG","GOOX","BK4533","GXPC","IGV","LU0128525929.USD","LU0878866978.SGD","LU1823568750.SGD","SOCL","IE00BJJMRX11.SGD","IE00BN8TJ469.HKD","LU1721428933.USD","HK0000819398.USD","LU2247934214.USD","BK4514","LU2286300806.USD","LU1282649810.SGD","LU1839511570.USD","LU2592432038.USD","LU0130102774.USD","MSFT","AAPU","TRFK","LU2505996509.AUD","NVDU","LU0323240290.USD","LU0256863811.USD","ILDR","BK4602","07366","LU0823414551.USD","HK0000914660.USD","LU1232071149.USD","NULC","AAPX","LU2087621335.USD","IE00BGHQDM52.EUR","SSPC","NVDL","LU0211326839.USD","LFGY","LU0251142724.SGD","CHPS","SNVDAmain","IE00B4YYXB79.USD","LU1861215975.USD","LU2083900584.USD","LU2089985449.USD","BK4515","IE00BWXC8680.SGD","IE000Q6AESB8.SGD","LU0097036916.USD","LU1815336760.USD","TTXU","LU1057294990.SGD","LU1582987324.SGD","CWI","LU1201861249.SGD","LU1956131251.USD","GOU","LU1244550577.SGD","LU2404859741.USD","BK4077","LU0345770308.USD","NVDO","SPCG","LU0472753341.HKD","LU1116320737.USD","LU1119994496.HKD","LU0061475181.USD","LU0985489474.SGD","LU1623119135.USD","LU1267930730.SGD","LU1280957306.USD","LU2210150020.SGD","LU2272731782.SGD","LU2473716301.USD","SG9999015341.SGD","LU2322448791.USD","LU0079474960.USD","LU1804176565.USD","LU2746668974.SGD","LU2023250330.USD","TSLS","LU2360107168.USD","BK4576","LU0823397285.USD","LU1121112475.USD","LU2237443978.SGD","SG9999015358.SGD","DIPS","IE00B42XCP33.USD","LU1023059063.AUD","LU2063271972.USD","SGXZ23171101.USD","LU0823416689.USD","SKHY","TESL","BK4511","JGRO","LU1691799644.USD","LU0476273544.USD","LU0823397103.USD","SG9999001176.SGD","ELOL","IE00B775H168.HKD","GDOC","LU2111349929.HKD","LU0048573561.USD","LEGR","IE00B7SZLL34.SGD","LU1061106388.HKD","LU1127390331.HKD","LU1496350171.SGD","WANT","IE00B1XK9C88.USD","LU2361044865.SGD","LLYX","MULL","LU1181866309.USD","LU2471134523.USD","LU2471134879.HKD","LU2860962120.EUR","LU0198837287.USD","LU0784385170.HKD","ASIA","LU1861220033.SGD","SKHU","LU1934455194.USD","LU0208291251.USD","LU0871640123.AUD","LU0081259029.USD","LU0203347892.USD","BK4605","AVS","LU0672654240.SGD","IE000SO60NU8.SGD","LU1323610961.USD","SMH","IE00BYXW3230.USD","LU0130517989.USD","LU2931357623.SGD","IE00BHPRN162.USD","LU1989771016.USD","LU2092937148.SGD","LU2125909247.SGD","MSFL","LU1670711123.USD","LU0053666078.USD","LU1868837300.USD","GOGL","LU1861558580.USD","LU1989772840.SGD","BK4554","SG9999001424.SGD","09788","LU0456855351.SGD","NVDG","SAMZNmain","IE00B5949003.HKD","BK4525","LU0820561818.USD","LU1815333072.USD","LU2125154935.USD","SG9999014914.USD","LU0757359954.USD","SGXZ51526630.SGD","LU0130103400.USD","LU1429558221.USD","IE00BK4W5M84.HKD","AGOX","IE00BJLML261.HKD","LU1059921491.USD","LU0203345920.USD","LU0354030438.USD","LU1206712785.SGD","SG9999002232.USD","LU0056508442.USD","TSMX","IE00BDCRKT87.USD","LU2242650005.HKD","LU1201861165.SGD","FXL","BK4528","IE00B19Z3581.USD","LU0215105999.USD","LU0251132253.USD","OGIG","LU0553294199.USD","LU2237957811.SGD","SG9999014542.SGD","GOOL","IOSX","LU1508157978.USD","IE00BYQQ9H92.USD","GOOY","ARTY","HYNX","SG9999013999.USD","LU2211817866.USD","LU0820562030.AUD","LU2506951875.HKD","NVDY","LU1934455277.USD","DRMY","LU0868494708.USD","LU2413666699.HKD","METD","BK4529","TSLT","3NVD.UK","IE0004091025.USD","BK4543","SKYY","LU0985320562.USD","AVGO","HK0000304797.USD","LU2430703178.SGD","BOBP","LU0545039389.USD","LU2098885051.SGD","LU2456880835.USD","ROM","BK4007","SG9999001440.SGD","SGXZ80539844.SGD","LU1267930573.SGD","LU0312595415.SGD","BK4504","IE00B19Z3B42.SGD","LU0572940350.SGD","BK4608","LU0690374961.EUR","AMZD","LU2097829019.USD","SG9999015945.SGD","IE0009G5SDU7.USD","LU0861579265.USD","LU2023250504.SGD","PSI","09766","LU2324357040.USD","LU0466842654.USD","LU0882574055.USD","HK0000320223.HKD","CLSE","LU0143863784.USD","LU2112291526.USD","METV","LU0943347566.SGD","CQTM","ADVE","IE0009355771.USD","LU1645745479.HKD","TSDD","SMOG","IE00BMPRXQ63.HKD","AMZW","LU0170899867.USD","LU0912757837.SGD","NVD","TEK","FHLC","MUD","LU2663582299.SGD","LU2394011477.USD","LU0823434740.USD","AVGX","WLDR","LU1633808545.USD","LU2298321311.HKD","LU1989773731.SGD","LU0541501648.USD","LU2430703095.HKD","LU1035775433.USD","BK4612","IE000MB6IJN5.SGD","RXL","SPWO","LU0154236417.USD","LU1979441026.SGD","TMED","BLOX","BK4599","LU1244550221.USD","SG9999002224.SGD","SG9999017495.SGD","IE000ITXATA3.USD","LU0174119429.USD","MEDX","LU0130518102.USD","LU2237957902.USD","HK0000306701.USD","ABFL","LU0068578508.USD","LU1074936037.SGD","LU1564329115.USD","FAI","BK4512","SOX","LU0210536198.USD","LU1917777945.USD","LU2720916845.USD","LU2023251221.USD","LU0417517546.SGD","LU1670756490.USD","LU0345769631.USD","IE00BSNM7G36.USD","LU0345774391.USD","LU0289941410.SGD","LU1894683348.USD","LU0494093205.USD","LU0471298694.HKD","LU0823421416.USD","LU0234572021.USD","EMSF","LU1989772923.USD","LU1144417596.USD","BK4220","LU2462157665.USD","SKHX","LU2211814178.USD","07788","IE00B19Z9505.USD","SPCM","LU2433249047.HKD","IE00B4R5TH58.HKD","LU0433182093.SGD","TSLR","SGXZ99366536.SGD","BK4507","IE0001KFT4U8.USD","LU1992135399.USD","LU2125909916.SGD","LU0477156953.USD","LU0211327993.USD","LU0265550359.USD","LU0648000940.SGD","LU0889566641.SGD","LU0124676726.USD","LU2097344357.USD","LU1732799900.SGD","LU0689472784.USD","LU2106854487.HKD","LU0719512351.SGD","SHOC","LU0171293334.USD","LU0133085943.USD","LU0061474705.USD","LU2133065610.SGD","GB00B4QBRK32.GBP","SNPE","LU0557290698.USD","LU0444971666.USD","IE000W1ABFV2.USD","LU2237443465.HKD","BK4553","HK0000532082.HKD","IE00BQXX3D17.EUR","LU0572939691.SGD","IXJ","BK4592","TSII","AMZN","LU0894485498.HKD","LU1720051108.HKD","LU1861127337.USD","LU2355687059.USD","GOOGL","CMAG","LU0149725797.USD","LU0077335932.USD","FTEC","LU2505996681.GBP","LU1868836914.USD","LU0289960550.SGD","07766","SAVGOmain","IE00BYV24P56.USD","AMZZ","LU0265550946.USD","LU2347655156.SGD","IE0009356076.USD","BK4614","WUGI","IE00BVYPNP33.GBP","LU1206713676.USD","LU1868837722.USD","LU0980610538.SGD","LIT","LU1043141123.HKD","ESUM","LU2360106947.USD","LU0792757196.USD","LU1048588211.SGD","09366","TRUH","LU1064131342.USD","MUZ","LU0070217475.USD","LU1923623000.USD","SG9999018857.SGD","CIBR","IE00BLSP4239.USD","OZEM","LU0114720955.EUR","LU1988902786.USD","LU1699723380.USD","LU2896262040.SGD","LU1582986359.USD","LU1674673428.USD","LU1585245621.USD","IE00BFSS7M15.SGD","ESLG","LU0384037296.USD","NVYY","CGIC","TESC","LU2100268510.USD","TSMU","BK4573","HRTS","FBX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664850457","title":"H.C. Wainwright says Novartis success in RMS trials does not impact TG’s Briumvi","url":"https://stock-news.laohu8.com/highlight/detail?id=2664850457","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664850457?lang=en_us&edition=fundamental","pubTime":"2026-09-01 23:35","pubTimestamp":1788276922,"startTime":"0","endTime":"0","summary":"After Novartis (NVS) announced topline data from the REMODEL-1/-2 trials of remibrutinib in relapsing multiple sclerosis, H.C. Wainwright analyst E...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/h-c-wainwright-says-novartis-success-in-rms-trials-does-not-impact-tgs-briumvi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/h-c-wainwright-says-novartis-success-in-rms-trials-does-not-impact-tgs-briumvi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","IE0002141913.USD","BK4532","IE00BJJMRZ35.SGD","NVS","BK4588","IE00B2B36J28.USD","IE00B4R5TH58.HKD","PPH","BK4578","MEDX","IE00BFTCPJ56.SGD","LU0208291251.USD","LU0320765489.SGD","IE00BJT1NW94.SGD","LU0070302665.USD","BK4007","IE0009355771.USD","LU0211331839.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664527668","title":"Novartis MS Trials Open Door to Multibillion-Dollar Sales Opportunity","url":"https://stock-news.laohu8.com/highlight/detail?id=2664527668","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664527668?lang=en_us&edition=fundamental","pubTime":"2026-09-01 22:27","pubTimestamp":1788272820,"startTime":"0","endTime":"0","summary":"1427 GMT - Novartis's latest trial results for a multiple sclerosis drug suggest a multibillion-dollar sales opportunity is within the Swiss drugmaker's reach, analysts at J.P. Morgan say in a research note. The results for Novartis's Rhapsido reduce risk on a sales opportunity of at least $2 billion to $3 billion in relapsing multiple sclerosis alone, according to JPM. Given that consensus forecasts for 2030 sales from the drug currently stand at $3.4 billion, mainly from skin conditions, consensus estimates could see significant upgrades after the results, the analysts say. That said, detailed data are required to assess the drug's potential relative to Roche's fenebrutinib and so-called anti-CD20 therapies, a different class of medicines, they add. Novartis shares jump 6.3%.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJJMRZ35.SGD","LU0208291251.USD","BK4585","BK4007","LU0211331839.USD","NVS","BK4532","IE0009355771.USD","PPH","IE00B2B36J28.USD","IE0002141913.USD","IE00BJT1NW94.SGD","IE00B4R5TH58.HKD","LU0070302665.USD","MEDX","BK4578","BK4588","LU0320765489.SGD","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664886818","title":"Johnson & Johnson (JNJ) Stock May Trade At A Discount As Europe Backs Tecvayli","url":"https://stock-news.laohu8.com/highlight/detail?id=2664886818","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664886818?lang=en_us&edition=fundamental","pubTime":"2026-09-01 22:26","pubTimestamp":1788272814,"startTime":"0","endTime":"0","summary":"Johnson & Johnson stock has delivered a 3 year total return of 80.4%, yet the latest valuation checks send mixed signals, with the Discounted Cash Flow (DCF) intrinsic value pointing to upside while market based multiples suggest the shares are not cheap.\n\nThe 80.4% gain over the past 3 years points to strong shareholder rewards that may already reflect a lot of optimism in Johnson & Johnson.\nRecent approvals for TECVAYLI in Europe and IMAAVY in the US can support long term cash flow...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/139677-main-header/1756253951625","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/139677-main-header/1756253951625"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-jnj/johnson-johnson/news/johnson-johnson-jnj-stock-may-trade-at-a-discount-as-europe","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-jnj/johnson-johnson/news/johnson-johnson-jnj-stock-may-trade-at-a-discount-as-europe","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["JOYT","GXDW","LU1929549753.HKD","JNJ","LU1935042991.SGD","LU1894683264.USD","IE00BJJMRZ35.SGD","LU1291159041.SGD","IHE","LU0426412945.USD","LU1718418525.SGD","IE000WAW04H5.SGD","BMED","BK4007","FTXH","LU0345769128.USD","IXJ","LU2236285917.USD","VHT","BK4568","LU0203345920.USD","PJP","LU0162691827.USD","RXL","IE00B2B36J28.USD","LU0820561909.HKD","TRUH","FHLC","LU2602419157.SGD","RGLO","SPHQ","LU0882574055.USD","IE00BLSP4239.USD","DECU","VOTE","MEDX","IE00BFXG1179.USD","JDOC","XLV","BK4504","BK4532","PMDE","GDOC","SGXZ57979304.SGD","IYH","VGFPF","DCF","FEBU","LU1989771016.USD","LU0792757196.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664852288","title":"Novartis Stock (NVS) Pops as Multiple Sclerosis Drug Shows Positive Results in Late-Stage Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2664852288","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664852288?lang=en_us&edition=fundamental","pubTime":"2026-09-01 22:17","pubTimestamp":1788272261,"startTime":"0","endTime":"0","summary":"Novartis ($NVS) stock rose about 6% at the time of writing on Tuesday, after the Swiss drugmaker reported positive results from two late-stage tria...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/novartis-stock-nvs-pops-as-multiple-sclerosis-drug-shows-positive-results-in-late-stage-trials?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/novartis-stock-nvs-pops-as-multiple-sclerosis-drug-shows-positive-results-in-late-stage-trials?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","BK4588","LU0320765489.SGD","MEDX","IE00BJT1NW94.SGD","BK4585","IE00B2B36J28.USD","BK4578","LU0208291251.USD","BK4007","LU0070302665.USD","BK4532","NVS","LU0211331839.USD","PPH","IE0009355771.USD","IE0002141913.USD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664785240","title":"Novartis AG Stock (NVS) Moved Up by 6.54% on Sep 1: Drivers Behind the Movement","url":"https://stock-news.laohu8.com/highlight/detail?id=2664785240","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664785240?lang=en_us&edition=fundamental","pubTime":"2026-09-01 22:15","pubTimestamp":1788272126,"startTime":"0","endTime":"0","summary":"• Remibrutinib succeeded in Phase III multiple sclerosis trials, showing clinical superiority.\n• Novartis paused eight early-stage CAR-T trials following three patient deaths.\n• The company reports $56.33B annual revenue and $13.98B net profit.","market":"nz","thumbnail":"https://resource.tradingkey.com/uploads/20251024/Novartis-369e71de347f479fa3f300f9d7904bc5.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20251024/Novartis-369e71de347f479fa3f300f9d7904bc5.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262144163-market-movers-nvs-20260901","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","NVS","IE00BFTCPJ56.SGD","LU0211331839.USD","IE00B4R5TH58.HKD","BK4007","IE0002141913.USD","MEDX","IE00B2B36J28.USD","IE0009355771.USD","BK4585","LU0320765489.SGD","BK4532","BK4578","LU0208291251.USD","BK4588","PPH","LU0070302665.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664150852","title":"Novartis's Multiple Sclerosis Trial Results Match Best Hopes","url":"https://stock-news.laohu8.com/highlight/detail?id=2664150852","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664150852?lang=en_us&edition=fundamental","pubTime":"2026-09-01 22:14","pubTimestamp":1788272040,"startTime":"0","endTime":"0","summary":"1414 GMT - Novartis's trial results for a multiple sclerosis drug are in line with a blue-sky scenario, UBS analysts say in a research note. The Swiss drugmaker's results from two late-stage studies point to a greater reduction in annualized relapse rates with its Rhapsido compared to Sanofi's Aubagio, with no liver safety issues, the analysts say. These results suggest Novartis's drug might be at least a best-in-class oral medicine for the disease, according to UBS. UBS estimates that there's a 50% probability the drug's sales for relapsing multiple sclerosis reach $4.5 billion. Novartis shares jump 6.2%.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","IE0002141913.USD","SOCL","BK4508","BK4578","IE00BJT1NW94.SGD","MEDX","LU0208291251.USD","LU1863844749.USD","LU0320765489.SGD","BK4534","IE00BFTCPJ56.SGD","NVS","IE0034235071.USD","IE00BJJMRZ35.SGD","BK4118","IE00B2B36J28.USD","PPH","LU0240878834.USD","MTCH","BK4532","LU0211331839.USD","LU0205194284.USD","BK4077","BK4588","LU0240877869.USD","BK4585","UBS","IE00B4R5TH58.HKD","IE0009355771.USD","LU0205193047.USD","LU1863844665.USD","LU3187612489.SGD","LU1829250122.USD","BK4549","LU0070302665.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148610163","title":"US Stock Alert: Novartis Gains 5% On Positive Late-Stage Trial Results For MS Oral Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=1148610163","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148610163?lang=en_us&edition=fundamental","pubTime":"2026-09-01 22:00","pubTimestamp":1788271219,"startTime":"0","endTime":"0","summary":"On Tuesday, shares of Novartis AG (NVS.US) climbed more than 5% to trade at $160.82 apiece. The surge follows the company's announcement that its investigational oral therapy, remibrutinib, met key...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK4007","PPH","LU0211331839.USD","IE00BJT1NW94.SGD","BK4578","LU0320765489.SGD","BK4585","IE00BFTCPJ56.SGD","01477","LU0070302665.USD","BK1574","BK4588","IE00B2B36J28.USD","BK4532","IE0009355771.USD","NVS","MEDX","IE00BJJMRZ35.SGD","IE0002141913.USD","IE00B4R5TH58.HKD","LU0208291251.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664485406","title":"Novartis up Nearly 6%, on Pace for Largest Percent Increase Since March 2023","url":"https://stock-news.laohu8.com/highlight/detail?id=2664485406","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664485406?lang=en_us&edition=fundamental","pubTime":"2026-09-01 21:54","pubTimestamp":1788270840,"startTime":"0","endTime":"0","summary":"Novartis AG Sponsored ADR  is currently at $160.98, up $8.92 or 5.87%--Would be highest close since March 10, 2026, when it closed at $161.59--On pace for largest percent increase since March 27, 2023, when it rose 8%--Snaps a four day losing streak--Up 16.76% year-to-date--Down 4.53% from its all-time closing high of $168.62 on Feb. 27, 2026--Up 27.12% from 52 weeks ago , when it closed at $126.64--Down 4.53% from its 52-week closing high of $168.62 on Feb. 27, 2026--Up 32.17% from its 52-week closing low of $121.80 on Oct. 29, 2025--Traded as high as $163.57; highest intraday level since March 4, 2026, when it hit $165.69--Up 7.57% at today's intraday high; largest intraday percent increase since March 27, 2023, when it rose as much as 8.37%All data as of 9:52:05 AM ETSource: Dow Jones Market Data, FactSet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","MEDX","IE00B4R5TH58.HKD","NVS","IE00BJT1NW94.SGD","LU0070302665.USD","BK4007","IE00B2B36J28.USD","PPH","IE0002141913.USD","LU0320765489.SGD","IE00BFTCPJ56.SGD","BK4578","IE0009355771.USD","IE00BJJMRZ35.SGD","BK4532","LU0211331839.USD","BK4585","LU0208291251.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":16,"pageCount":15,"totalSize":316,"code":"91000000","status":"200"}]}}